Effects of Rosuvastatin and Atorvastatin on LDL and HDL Particle Concentrations in Patients With Metabolic Syndrome: A randomized, double-blind, controlled study

por Rosenson, Robert S., Otvos, James D., Hsia, Judith
Publicado 2009

High-throughput nuclear magnetic resonance measurement of citrate in serum and plasma in the clinical laboratory

por Garcia, Erwin, Connelly, Margery A., Matyus, Steven P., Otvos, James D., Shalaurova, Irina
Publicado 2021

Lipoprotein-X and Lipoprotein-Z Induced Hyperviscosity Syndrome in the Setting of Cholestatic Liver Failure

por Waksman, Ori, Cho, Daniel J., Kim, HyoungSup, Otvos, James D., Rosenson, Robert S.
Publicado 2022

Novel measures of inflammation and insulin resistance are related to obesity and fitness in a diverse sample of 11–14 year-olds: The HEALTHY Study

por Jago, Russell, Drews, Kimberly L., Otvos, James D., Willi, Steven M., Buse, John B.
Publicado 2016

GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk

por Connelly, Margery A., Otvos, James D., Shalaurova, Irina, Playford, Martin P., Mehta, Nehal N.
Publicado 2017

Lipoprotein Particle Size and Concentration by Nuclear Magnetic Resonance and Incident Type 2 Diabetes in Women

por Mora, Samia, Otvos, James D., Rosenson, Robert S., Pradhan, Aruna, Buring, Julie E., Ridker, Paul M.
Publicado 2010

Adiponectin and Lipoprotein Particle Size

por Weiss, Ram, Otvos, James D., Flyvbjerg, Allan, Miserez, Andre R., Frystyk, Jan, Sinnreich, Ronit, Kark, Jeremy D.
Publicado 2009

Amount of hepatic fat predicts cardiovascular risk independent of insulin resistance among Hispanic-American adolescents

por Jin, Ran, Le, Ngoc-Anh, Cleeton, Rebecca, Sun, Xiaoyan, Cruz Muños, Jessica, Otvos, James, Vos, Miriam B
Publicado 2015

The NIH Lipo-COVID Study: A Pilot NMR Investigation of Lipoprotein Subfractions and Other Metabolites in Patients with Severe COVID-19

por Ballout, Rami A., Kong, Hyesik, Sampson, Maureen, Otvos, James D., Cox, Andrea L., Agbor-Enoh, Sean, Remaley, Alan T.
Publicado 2021

GlycA, hsCRP differentially associated with MI, ischemic stroke: In the Dallas Heart Study and Multi-Ethnic Study of Atherosclerosis: GlycA, hsCRP Differentially Associated MI, Str...

por Riggs, Kayla A., Joshi, Parag H., Khera, Amit, Otvos, James D., Greenland, Philip, Ayers, Colby R., Rohatgi, Anand
Publicado 2022

Increase in the Inflammatory Marker GlycA over 13 Years in Young Adults Is Associated with Poorer Cognitive Function in Midlife

por Cohen-Manheim, Irit, Doniger, Glen M., Sinnreich, Ronit, Simon, Ely S., Pinchas-Mizrachi, Ronit, Otvos, James D., Kark, Jeremy D.
Publicado 2015

GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function

por Gruppen, Eke G., Riphagen, Ineke J., Connelly, Margery A., Otvos, James D., Bakker, Stephan J. L., Dullaart, Robin P. F.
Publicado 2015

Ketone Bodies Are Mildly Elevated in Subjects with Type 2 Diabetes Mellitus and Are Inversely Associated with Insulin Resistance as Measured by the Lipoprotein Insulin Resistance I...

por Garcia, Erwin, Shalaurova, Irina, Matyus, Steven P., Oskardmay, David N., Otvos, James D., Dullaart, Robin P.F., Connelly, Margery A.
Publicado 2020

The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes

por Orchard, Trevor J., Cariou, Bertrand, Connelly, Margery A., Otvos, James D., Zhang, Shuyu, Antalis, Caryl J., Ivanyi, Tibor, Hoogwerf, Byron J.
Publicado 2017

Accuracy and Clinical Impact of Estimating Low-Density Lipoprotein-Cholesterol at High and Low Levels by Different Equations

por Sampson, Maureen, Wolska, Anna, Cole, Justine, Zubirán, Rafael, Otvos, James D., Meeusen, Jeff W., Donato, Leslie J., Jaffe, Allan S., Remaley, Alan T.
Publicado 2022

TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function

por Gruppen, Eke G., Garcia, Erwin, Connelly, Margery A., Jeyarajah, Elias J., Otvos, James D., Bakker, Stephan J. L., Dullaart, Robin P. F.
Publicado 2017

Association of High‐Density Lipoprotein Particles and High‐Density Lipoprotein Apolipoprotein C‐III Content With Cardiovascular Disease Risk According to Kidney Function: The Multi...

por Lamprea‐Montealegre, Julio A., McClelland, Robyn L., Otvos, James D., Mora, Samia, Koch, Manja, Jensen, Majken K., de Boer, Ian H.
Publicado 2019

Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children

por Connelly, Margery A., Shimizu, Chisato, Winegar, Deborah A., Shalaurova, Irina, Pourfarzib, Ray, Otvos, James D., Kanegaye, John T., Tremoulet, Adriana H., Burns, Jane C.
Publicado 2016

Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis

por Ormseth, Michelle J., Chung, Cecilia P., Oeser, Annette M., Connelly, Margery A., Sokka, Tuulikki, Raggi, Paolo, Solus, Joseph F., Otvos, James D., Stein, C. Michael
Publicado 2015

A Newly Developed Diabetes Risk Index, Based on Lipoprotein Subfractions and Branched Chain Amino Acids, is Associated with Incident Type 2 Diabetes Mellitus in the PREVEND Cohort

por Flores-Guerrero, Jose L., Gruppen, Eke. G., Connelly, Margery A., Shalaurova, Irina, Otvos, James D., Garcia, Erwin, Bakker, Stephan J. L., Dullaart, Robin P. F.
Publicado 2020